CBX3 and neoplasm: The exclusive increase of Cbx3/HP1γ-deficient CD8+ effector T cells in tumors and their subsequent disappearance when Lef1 is ablated suggest that LEF-1 is requisite for their persistence in varied tumor types irrespective of mutational status.